Clinical Trial Update: Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial investigating individualized dosing of ATG in haploidentical hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haploidentical Hematopoietic Stem Cell Transplantation

Drugs mentioned

• ATG (anti-thymocyte globulin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Haploidentical Hematopoietic Stem Cell Transplantation | Phase 2 | Status: UNKNOWN